View in EDS

Successful obinutuzumab administration after rituximab discontinuation due to intolerance in patients with hematologic disorders.

Saved in:
Bibliographic Details
Title: Successful obinutuzumab administration after rituximab discontinuation due to intolerance in patients with hematologic disorders.
Authors: Schieber T; Department of Pharmacy, James Cancer Hospital and Solove Research Institute at The Ohio State University, Columbus, OH., Li A; Department of Pharmacy, James Cancer Hospital and Solove Research Institute at The Ohio State University, Columbus, OH., Lundberg J; Department of Pharmacy, James Cancer Hospital and Solove Research Institute at The Ohio State University, Columbus, OH., Wiczer T; Department of Pharmacy, James Cancer Hospital and Solove Research Institute at The Ohio State University, Columbus, OH., Voorhees T; Department of Medicine-Hematology, James Cancer Hospital and Solove Research Institute at The Ohio State University, Columbus, OH.
Source: Blood advances [Blood Adv] 2023 Jul 25; Vol. 7 (14), pp. 3431-3434.
Publication Type: Journal Article
Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36877766
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Successful obinutuzumab administration after rituximab discontinuation due to intolerance in patients with hematologic disorders.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Schieber+T%22">Schieber T</searchLink>; Department of Pharmacy, James Cancer Hospital and Solove Research Institute at The Ohio State University, Columbus, OH.<br /><searchLink fieldCode="AU" term="%22Li+A%22">Li A</searchLink>; Department of Pharmacy, James Cancer Hospital and Solove Research Institute at The Ohio State University, Columbus, OH.<br /><searchLink fieldCode="AU" term="%22Lundberg+J%22">Lundberg J</searchLink>; Department of Pharmacy, James Cancer Hospital and Solove Research Institute at The Ohio State University, Columbus, OH.<br /><searchLink fieldCode="AU" term="%22Wiczer+T%22">Wiczer T</searchLink>; Department of Pharmacy, James Cancer Hospital and Solove Research Institute at The Ohio State University, Columbus, OH.<br /><searchLink fieldCode="AU" term="%22Voorhees+T%22">Voorhees T</searchLink>; Department of Medicine-Hematology, James Cancer Hospital and Solove Research Institute at The Ohio State University, Columbus, OH.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101698425%22">Blood advances</searchLink> [Blood Adv] 2023 Jul 25; Vol. 7 (14), pp. 3431-3434.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Hematology%22">American Society of Hematology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101698425 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2473-9537 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224739529%22">24739529 </searchLink><i>NLM ISO Abbreviation: </i>Blood Adv <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36877766
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1182/bloodadvances.2022009548
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 3431
    Titles:
      – TitleFull: Successful obinutuzumab administration after rituximab discontinuation due to intolerance in patients with hematologic disorders.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Schieber T
      – PersonEntity:
          Name:
            NameFull: Li A
      – PersonEntity:
          Name:
            NameFull: Lundberg J
      – PersonEntity:
          Name:
            NameFull: Wiczer T
      – PersonEntity:
          Name:
            NameFull: Voorhees T
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 25
              M: 07
              Text: 2023 Jul 25
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 2473-9537
          Numbering:
            – Type: volume
              Value: 7
            – Type: issue
              Value: 14
          Titles:
            – TitleFull: Blood advances
              Type: main
ResultId 1